Gauthier S - Search Results

1

Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.

Kahle-Wrobleski K, Andrews JS, Belger M, Ye W, Gauthier S, Rentz DM, Galasko D. Kahle-Wrobleski K, et al. Among authors: gauthier s. J Prev Alzheimers Dis. 2017;4(2):72-80. doi: 10.14283/jpad.2017.2. J Prev Alzheimers Dis. 2017. PMID: 29186278 Free PMC article.

2

Clinical and Economic Characteristics of Milestones along the Continuum of Alzheimer's Disease: Transforming Functional Scores into Levels of Dependence.

Kahle-Wrobleski K, Andrews JS, Belger M, Gauthier S, Stern Y, Rentz DM, Galasko D. Kahle-Wrobleski K, et al. Among authors: gauthier s. J Prev Alzheimers Dis. 2015;2(2):115-120. doi: 10.14283/jpad.2015.53. Epub 2015 Jan 20. J Prev Alzheimers Dis. 2015. PMID: 28775969 Free PMC article.

3

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Dubois B, et al. Among authors: gauthier s. Lancet Neurol. 2007 Aug;6(8):734-46. doi: 10.1016/S1474-4422(07)70178-3. Lancet Neurol. 2007. PMID: 17616482 Review.

4

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.

Bodick NC, Offen WW, Levey AI, Cutler NR, Gauthier SG, Satlin A, Shannon HE, Tollefson GD, Rasmussen K, Bymaster FP, Hurley DJ, Potter WZ, Paul SM. Bodick NC, et al. Among authors: gauthier sg. Arch Neurol. 1997 Apr;54(4):465-73. doi: 10.1001/archneur.1997.00550160091022. Arch Neurol. 1997. PMID: 9109749 Clinical Trial.

5

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.

Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ. Khachaturian ZS, et al. Among authors: gauthier s. Alzheimers Dement. 2008 May;4(3):156-63. doi: 10.1016/j.jalz.2008.03.005. Alzheimers Dement. 2008. PMID: 18631960 Free PMC article. No abstract available.

6

Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease.

Marcusson J, Bullock R, Gauthier S, Kurz A, Schwalen S. Marcusson J, et al. Among authors: gauthier s. Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17 Suppl 3:S86-91. doi: 10.1097/00002093-200307003-00005. Alzheimer Dis Assoc Disord. 2003. PMID: 14512822

7

Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease.

Rive B, Gauthier S, Costello S, Marre C, François C. Rive B, et al. Among authors: gauthier s. CNS Drugs. 2013 Jul;27(7):573-82. doi: 10.1007/s40263-013-0074-x. CNS Drugs. 2013. PMID: 23765561 Free PMC article. Review.

8

Alzhemed: a potential treatment for Alzheimer's disease.

Aisen PS, Gauthier S, Vellas B, Briand R, Saumier D, Laurin J, Garceau D. Aisen PS, et al. Among authors: gauthier s. Curr Alzheimer Res. 2007 Sep;4(4):473-8. doi: 10.2174/156720507781788882. Curr Alzheimer Res. 2007. PMID: 17908052 Review.

9

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.

Rösler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stähelin HB, Hartman R, Gharabawi M. Rösler M, et al. Among authors: gauthier s. BMJ. 1999 Mar 6;318(7184):633-8. doi: 10.1136/bmj.318.7184.633. BMJ. 1999. PMID: 10066203 Free PMC article. Clinical Trial.

10

EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease.

Gauthier S, Juby A, Rehel B, Schecter R. Gauthier S, et al. Int J Clin Pract. 2007 Jun;61(6):886-95. doi: 10.1111/j.1742-1241.2007.01387.x. Int J Clin Pract. 2007. PMID: 17504350 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,160 results

Search Page

Filters